Clinical Trial Update: Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the systematic use of desmopressin (DDAVP) to prevent serum sodium overcorrection in severe hyponatremia and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hyponatremia | Phase 3 | Status: RECRUITING